secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001193125-23-193295
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma effects 1-for-17 reverse stock split to meet Nasdaq minimum bid price
--------------------------------------------------------------------------------

- Reverse stock split of common stock at 1-for-17 ratio effective July 26, 2023 at 12:01 a.m. ET.
- Intended to bring company into compliance with Nasdaq $1.00 minimum bid price requirement for continued listing.
- No fractional shares issued; all fractional shares rounded up to nearest whole share.
- CUSIP changes to 08205P209; trading symbol BNTC remains unchanged.
- Stockholders need not take action; Computershare acts as exchange agent for the split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/0001193125-23-193295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523193295/d512923d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-193295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer